Copyright © 2026 GALAXIS TECHNOLOGY. All rights reserved.
Menu
Deliver exceptional customer value
Since its establishment, the company has always strictly followed the relevant laws and regulations as well as the rules, regulations and normative documents issued by the regulatory authorities, to establish and improve the internal management and control systems of the company, promote its standardized operation, and safeguard the legitimate rights and interests of the company.
Chair person of the Board, executive Director and chief executive officer
Executive Director and vice president
Executive Director and vice president
Executive Director and vice president
Mr. LI Qiuyu has served as a non-executive Director since June 2019, responsible for overseeing Board affairs and providing strategic advice on the Group’s business operations.
Mr. SHEN Qi has served as a non-executive Director since June 2025, responsible for overseeing Board affairs and providing strategic advice on the Group’s business operations.
Served as an independent non-executive Director since June 2025 (initially appointed as an independent director in July 2021), responsible for providing independent advice and judgment to the Board.
Served as an independent non-executive Director since June 2025, responsible for providing independent advice to the Board on financial management and accounting practices.
Served as an independent non-executive Director since June 2025 (initially appointed as an independent director in July 2021), responsible for providing independent advice and judgment to the Board.
Responsible for leading the Group’s strategic planning, business direction and overall management; Tenure as Director: since October 15, 2016.
Responsible for brand management, public relations oversight, industrial development planning and external strategic cooperation; Tenure as Director: since October 15, 2018.
Responsible for business development and market expansion; Tenure as Director: since November 15, 2016.
Responsible for leading the Group’s AI Research Institute and driving research, development and application in intelligent logistics; Tenure as Senior Management: since October 1, 2018.
Responsible for financial management, board affairs and capital operation related work; Tenure as Senior Management: since January 13, 2025.
Responsible for overall business operation and human resource management; Tenure as Senior Management: since November 30, 2017.
Our Company has established four committees under the Board in accordance with the relevant laws and regulations in mainland China, the Articles and the code of corporate governance practices under the Listing Rules, including the Audit Committee, the Remuneration and Appraisal Committee, the Nomination Committee and the Strategy Committee.
We have established an Audit Committee in compliance with Rule 3.21 of the Listing Rules and the Corporate Governance Code set out in Appendix C1 to the Listing Rules. The primary duties of the Audit Committee are to (i) assisting our Board by providing an independent view of the effectiveness of the financial reporting process, internal control and risk management systems of our Group, (ii) overseeing the audit process, and (iii) performing other duties and responsibilities as assigned by our Board. TheAudit Committee comprises one non-executive Director, namely Mr. SHEN Qi and two independent non-executive Directors, namely, Mr. LAU Hak Lap and Mr. MO Rong. Mr. LAU Hak Lap is the chairperson of the Audit Committee. Mr. LAU holds the appropriate professional qualifications as required under Rules 3.10(2) and 3.21 of the Listing Rules.
We have established a Remuneration and Appraisal Committee in compliance with Rule 3.25 of the Listing Rules and the Corporate Governance Code set out in Appendix C1 to the Listing Rules. The primary duties of the Remuneration and Appraisal Committee are to (i) making recommendations to our Board on our policy and structure for all remuneration of Directors and senior management and on the establishment of a formal and transparent procedure for developing policy on such remuneration; (ii) determining the specific remuneration packages of all Directors and senior management; and (iii) reviewing and approving remuneration proposals in accordance with the corporate policies and objectives resolved by our Board. The Remuneration and Appraisal Committee comprises one executive Director, namely, Dr. BAI Hongxing, and two independent non-executive Directors, namely, Dr. HU Jianqiang and Mr. MO Rong. Mr. HU Jianqiang is the chairperson of the Remuneration and Appraisal Committee.
We have established a Nomination Committee in compliance with the Code on Corporate Governance set out in Appendix C1 to the Listing Rules. The primary duties of the Nomination Committee are to (i) reviewing the structure, size and composition of our Board, (ii) assessing the independence of independent non-executive Directors and (iii) making recommendations to our Board on matters relating to the appointment of Directors. The Nomination Committee comprises one executive Director, namely, Dr. YANG Yan, and two independent non-executive Directors, namely, Dr. HU Jianqiang and Mr. LAU Hak Lap. Dr. HU Jianqiang is the chairperson of the Nomination Committee.
We have established the Strategy Committee in compliance with the Article of Association. The primary duties of the Strategy Committee are to make recommendations to our Board on the long-term development strategy and major investments and projects of our Company. The Strategy Committee comprises one executive Director, namely, Dr. GU Chunguang and two independent non-executive Directors, namely, Dr. HU Jianqiang and Mr. MO Rong. Dr. GU Chunguang is the chairperson of the Strategy Committee.
IR Department
1118 Chicheng Road, Daqiao Town, Nanhu District, Jiaxing City, Zhejiang Province, China
Chair person of the Board, executive Director and chief executive officer
Dr. GU Chunguang, is our founder, chairperson of the Board, an executive Director and the chief executive officer of our Company. He was appointed as a Director in October 2016 and redesignated as an executive Director in June 2025. Dr. GU also holds directorships or supervisorships across all of five major subsidiaries namely Galaxis Wuxi, Hubei Galaxis Tongda Technology, Zhejiang Galaxis International Trade, Guangdong Galaxis Jiadi and Anhui Galaxis. He is mainly responsible for leading the strategic planning, business direction and overall management of our Group. Dr. GU has over 25 years of experience in the fields of supply chain management, logistics systems, and advanced logistics equipment technology. Before founding our Group, Dr. GU started his career at i2 Technologies in the United States from August 1999. Dr. GU worked at McKinsey & Consulting Company Inc., Shanghai from March 2005 to June 2008, with his last position as engagement manager. From February 2008 to November 2017, he served as the chief technology officer at Jointown Pharmaceutical Group Co., Ltd. (“Jointown Pharmaceutical”), a company listed on the Shanghai Stock Exchange (stock code: 600998). Dr. GU obtained a bachelor’s degree in engineering from Tsinghua University in the PRC in July 1993 and a Ph.D. in mechanical engineering from the Massachusetts Institute of Technology in the United States in February 2000. Besides, Dr. GU was qualified as a professor-level senior engineer by the Department of Human Resources and Social Security of Zhejiang Province in June 2020. In recognition of his outstanding contributions to the logistics and modern service field, Dr. GU was honored as a National Model Worker in the logistics industry by Ministry of Human Resources and Social Security and China Federation of Logistics & Purchasing, and one of China’s Top Ten Contributors to the Logistics Industry by China International Logistics Technology and Services Exhibition Committee and Modern Logistics News.
Contact our experts to discover the right automation solution for your business.